A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
Northwest Clinical Trials
Clinical research site in Boise, Idaho · NORTHWEST CLINICAL TRIALS, 888 N Cole Rd, Boise, ID 83704 · (208) 685-0600 · Website
As of July 2026, 1 paid clinical trial is recruiting at Northwest Clinical Trials in Boise, Idaho. Active studies at this site cover conditions such as Alzheimer Disease, Dementia and Plaque, Amyloid. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Northwest Clinical Trials (1)
More research sites in Boise
- Saint Luke's Cancer Institute - Boise (81 trials)
- Saint Alphonsus Cancer Care Center-Boise (59 trials)
- Treasure Valley Medical Research (7 trials)
- St. Luke's Boise Medical Center (6 trials)
- Saint Alphonsus Regional Medical Center (5 trials)
- Boise VA Medical Center (4 trials)
- Advanced Specialty Research (3 trials)
- Consultants in Epilepsy and Neurology, PLLC (3 trials)
- ASR, LLC (3 trials)
- St. Luke's Cancer Institute: Boise (3 trials)